HEADER HYDROLASE/HYDROLASE INHIBITOR 24-FEB-15 4YES TITLE THROMBIN IN COMPLEX WITH (S)-(4-CHLORO-2-((1-(5-METHYL-1H-PYRROLE-2- TITLE 2 CARBONYL)PYRROLIDINE-2-CARBOXAMIDO)METHYL)PHENYL)METHANAMINIUM COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: COAGULATION FACTOR II; COMPND 5 EC: 3.4.21.5; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: COAGULATION FACTOR II; COMPND 11 EC: 3.4.21.5; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HIRUDIN; COMPND 15 CHAIN: H; COMPND 16 FRAGMENT: UNP RESIDUES 54-65; COMPND 17 SYNONYM: HIRUDIN-1,HIRUDIN-I,LEPIRUDIN; COMPND 18 ENGINEERED: YES; COMPND 19 OTHER_DETAILS: AC-GLY-ASP-PHE-GLU-GLU-ILE-PRO-GLU-GLU-TYS-LEU-GLN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: F2; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 18 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 19 ORGANISM_TAXID: 6421 KEYWDS SULFO-HIRUDIN, INHIBITOR, COMPLEX, THROMBIN, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 4 15-NOV-23 4YES 1 REMARK REVDAT 3 27-SEP-23 4YES 1 HETSYN REVDAT 2 29-JUL-20 4YES 1 COMPND SOURCE REMARK HETNAM REVDAT 2 2 1 LINK SITE REVDAT 1 17-JUN-15 4YES 0 JRNL AUTH H.R.CHOBANIAN,B.PIO,Y.GUO,H.SHEN,M.A.HUFFMAN,M.MADEIRA, JRNL AUTH 2 G.SALITURO,J.L.TEREBETSKI,J.ORMES,N.JOCHNOWITZ,L.HOOS, JRNL AUTH 3 Y.ZHOU,D.LEWIS,B.HAWES,L.MITNAUL,K.O'NEILL,K.ELLSWORTH, JRNL AUTH 4 L.WANG,T.BIFTU,J.L.DUFFY JRNL TITL IMPROVED STABILITY OF PROLINE-DERIVED DIRECT THROMBIN JRNL TITL 2 INHIBITORS THROUGH HYDROXYL TO HETEROCYCLE REPLACEMENT. JRNL REF ACS MED.CHEM.LETT. V. 6 553 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26005532 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00047 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 53182 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1067 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.54 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.95 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3044 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2680 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2972 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE : 0.3098 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.37 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 72 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2342 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.99520 REMARK 3 B22 (A**2) : 3.39120 REMARK 3 B33 (A**2) : 3.60400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.61110 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.228 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2451 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3318 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 850 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 61 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 354 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2451 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 301 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2915 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.31 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YES COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000207329. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53201 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.54700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1A2C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28 % PEG 2000 MME, 100MM BISTRIS, PH REMARK 280 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.88500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.59500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.88500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.59500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 328 REMARK 465 PHE A 329 REMARK 465 GLY A 330 REMARK 465 SER A 331 REMARK 465 ASP A 361 REMARK 465 GLY A 362 REMARK 465 ARG A 363 REMARK 465 TRP B 511 REMARK 465 THR B 512 REMARK 465 ALA B 513 REMARK 465 ASN B 514 REMARK 465 VAL B 515 REMARK 465 GLY B 516 REMARK 465 LYS B 517 REMARK 465 ACE H 53 REMARK 465 GLY H 54 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 ARG A 353 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 433 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 611 CG CD CE NZ REMARK 470 GLN B 619 CG CD OE1 NE2 REMARK 470 GLU H 58 CG CD OE1 OE2 REMARK 470 GLU H 61 CG CD OE1 OE2 REMARK 470 GLN H 65 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 342 -88.58 -131.07 REMARK 500 ASN B 416 73.41 -157.91 REMARK 500 HIS B 429 -62.84 -134.57 REMARK 500 GLU B 457 -71.62 -109.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 701 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ARG B 596 O REMARK 620 2 LYS B 599 O 94.4 REMARK 620 3 HOH B 865 O 90.0 91.9 REMARK 620 4 HOH B 874 O 108.7 156.1 82.1 REMARK 620 5 HOH B 889 O 163.9 71.9 82.2 84.3 REMARK 620 6 HOH B 952 O 99.3 82.8 169.5 99.1 87.6 REMARK 620 N 1 2 3 4 5 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-[2-(AMINOMETHYL)-5-CHLOROBENZYL]-1-[(5-METHYL-1H- REMARK 630 PYRROL-2-YL)CARBONYL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 45S B 704 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 5M1 PRO 00T REMARK 630 DETAILS: NULL DBREF 4YES A 328 363 UNP P00734 THRB_HUMAN 328 363 DBREF 4YES B 364 622 UNP P00734 THRB_HUMAN 364 622 DBREF 4YES H 54 65 UNP P01050 HIRV1_HIRME 54 65 SEQADV 4YES ACE H 53 UNP P01050 ACETYLATION SEQRES 1 A 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 A 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 A 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 H 13 ACE GLY ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU GLN MODRES 4YES TYS H 63 TYR MODIFIED RESIDUE HET TYS H 63 16 HET MG B 701 1 HET GOL B 702 6 HET NAG B 703 14 HET 45S B 704 26 HETNAM TYS O-SULFO-L-TYROSINE HETNAM MG MAGNESIUM ION HETNAM GOL GLYCEROL HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 45S N-[2-(AMINOMETHYL)-5-CHLOROBENZYL]-1-[(5-METHYL-1H- HETNAM 2 45S PYRROL-2-YL)CARBONYL]-L-PROLINAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 TYS C9 H11 N O6 S FORMUL 4 MG MG 2+ FORMUL 5 GOL C3 H8 O3 FORMUL 6 NAG C8 H15 N O6 FORMUL 7 45S C19 H23 CL N4 O2 FORMUL 8 HOH *231(H2 O) HELIX 1 AA1 PHE A 342 SER A 346 5 5 HELIX 2 AA2 THR A 351 TYR A 359 1 9 HELIX 3 AA3 ALA B 404 CYS B 407 5 4 HELIX 4 AA4 PRO B 411 ASP B 414 5 4 HELIX 5 AA5 THR B 418 ASN B 420 5 3 HELIX 6 AA6 ASP B 485 LEU B 493 1 9 HELIX 7 AA7 GLU B 532 SER B 539 1 8 HELIX 8 AA8 LYS B 554 GLY B 558 5 5 HELIX 9 AA9 LEU B 609 GLY B 621 1 13 HELIX 10 AB1 PRO H 60 GLN H 65 1 6 SHEET 1 AA1 7 SER B 368 ASP B 369 0 SHEET 2 AA1 7 GLN B 524 PRO B 529 -1 O VAL B 525 N SER B 368 SHEET 3 AA1 7 LYS B 498 GLY B 503 -1 N VAL B 501 O VAL B 526 SHEET 4 AA1 7 PRO B 571 LYS B 575 -1 O VAL B 573 N ARG B 500 SHEET 5 AA1 7 TRP B 582 TRP B 590 -1 O TYR B 583 N MET B 574 SHEET 6 AA1 7 GLY B 601 HIS B 605 -1 O PHE B 602 N TRP B 590 SHEET 7 AA1 7 MET B 548 ALA B 551 -1 N PHE B 549 O TYR B 603 SHEET 1 AA2 7 GLN B 378 ARG B 383 0 SHEET 2 AA2 7 GLU B 388 LEU B 395 -1 O GLU B 388 N ARG B 383 SHEET 3 AA2 7 TRP B 400 THR B 403 -1 O LEU B 402 N SER B 394 SHEET 4 AA2 7 ALA B 464 LEU B 468 -1 O ALA B 464 N THR B 403 SHEET 5 AA2 7 LYS B 440 ILE B 449 -1 N GLU B 445 O LYS B 467 SHEET 6 AA2 7 LEU B 422 ILE B 426 -1 N VAL B 424 O SER B 442 SHEET 7 AA2 7 GLN B 378 ARG B 383 -1 N PHE B 382 O LEU B 423 SHEET 1 AA3 2 LEU B 409 TYR B 410 0 SHEET 2 AA3 2 LYS B 415 ASN B 416 -1 O LYS B 415 N TYR B 410 SSBOND 1 CYS A 336 CYS B 482 1555 1555 2.06 SSBOND 2 CYS B 391 CYS B 407 1555 1555 2.04 SSBOND 3 CYS B 536 CYS B 550 1555 1555 2.02 SSBOND 4 CYS B 564 CYS B 594 1555 1555 2.04 LINK ND2 ASN B 416 C1 NAG B 703 1555 1555 1.43 LINK C GLU H 62 N TYS H 63 1555 1555 1.35 LINK C TYS H 63 N LEU H 64 1555 1555 1.36 LINK O ARG B 596 MG MG B 701 1555 1555 2.28 LINK O LYS B 599 MG MG B 701 1555 1555 2.35 LINK MG MG B 701 O HOH B 865 1555 1555 2.67 LINK MG MG B 701 O HOH B 874 1555 1555 2.42 LINK MG MG B 701 O HOH B 889 1555 1555 2.49 LINK MG MG B 701 O HOH B 952 1555 1555 2.36 CISPEP 1 SER B 385 PRO B 386 0 -3.40 CRYST1 69.770 71.190 72.810 90.00 100.64 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014333 0.000000 0.002693 0.00000 SCALE2 0.000000 0.014047 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013975 0.00000